Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cysteine-lowering Treatment With Mesna Against Obesity: Phase I Dose-finding Study

NCT04449536 is registered in ClinicalTrials.gov with University of Oslo as lead sponsor.

NCT NCT04449536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04449536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cysteine-lowering Treatment With Mesna Against Obesity: Phase I Dose-finding Study
Lead sponsor
University of Oslo
Phase
Phase 1
Overall status
Completed
Start date
November 2, 2020
Completion date
October 21, 2021
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug effect, obesity